Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 5/2014

01-09-2014 | Original Article

A susceptibility haplotype within the endothelial nitric oxide synthase gene influences bone mineral density in hypertensive women

Authors: Monica Singh, Puneetpal Singh, Surinder Singh, Pawan Kumar Juneja, Taranpal Kaur

Published in: Journal of Bone and Mineral Metabolism | Issue 5/2014

Login to get access

Abstract

The influence of the coordinated effect of various single-nucleotide polymorphisms (SNPs) within the endothelial nitric oxide synthase (eNOS) gene on the risk of osteoporosis in hypertension has remained undetermined. Four pertinent SNPs of the eNOS gene, rs2070774, rs1799983, rs1800780 and rs3918181, were examined for the risk of osteoporosis in 313 hypertensive postmenopausal women in Northwest India. All the hypertensive women were verified with dual energy X-ray absorptiometry and categorized as 150 with osteoporosis and 163 without osteoporosis. The minor allele (T) of rs1799983 exerts a statistically significant risk for osteoporosis both in dominant [odds ratio (OR) 3.71, 95 % confidence interval (CI) 2.12–6.49, P < 0.001] and recessive mode (OR 5.75, 95 % CI 1.24–26.69, P = 0.036) after Bonferroni correction. Bone mineral density (BMD) values (corrected for the effects of risk variables) according to eNOS SNP genotypes revealed a significant association with rs1799983 at both the lumbar spine (P = 0.001) and femoral neck (P = 0.023). Risk association analyses revealed a susceptibility haplotype TTAG which influences the risk of osteoporosis (OR 2.02, 95 % CI 1.05–3.39, P = 0.042) in hypertension after adjusting for the effects of risk factors. Furthermore, this haplotype was significantly associated with BMD at the lumbar spine (P = 0.029) and femoral neck (P = 0.021) in a dose-dependent manner. The results suggest that possession of the TTAG haplotype of the eNOS gene may increase the risk of osteoporosis two-fold in hypertensive postmenopausal women in Northwest India.
Literature
1.
go back to reference Strazzullo P, Nunziata V, Cirillo M, Giannattasio R, Ferrara LA, Mattioli PL, Mancini M (1983) Abnormalities of calcium metabolism in essential hypertension. Clin Sci (Lond) 65:137–141 Strazzullo P, Nunziata V, Cirillo M, Giannattasio R, Ferrara LA, Mattioli PL, Mancini M (1983) Abnormalities of calcium metabolism in essential hypertension. Clin Sci (Lond) 65:137–141
2.
go back to reference Hvarfner A, Bergstrom R, Morlin C, Wide L, Ljunghall S (1987) Relationship between calcium metabolic indices and blood pressure in patients with essential hypertension as compared with a healthy population. J Hypertens 5:451–456PubMedCrossRef Hvarfner A, Bergstrom R, Morlin C, Wide L, Ljunghall S (1987) Relationship between calcium metabolic indices and blood pressure in patients with essential hypertension as compared with a healthy population. J Hypertens 5:451–456PubMedCrossRef
3.
go back to reference Wang TM, Hsu JF, Jee WS, Matthews JL (1993) Evidence for reduced cancellous bone mass in the spontaneously hypertensive rat. Bone Miner 20:251–264PubMedCrossRef Wang TM, Hsu JF, Jee WS, Matthews JL (1993) Evidence for reduced cancellous bone mass in the spontaneously hypertensive rat. Bone Miner 20:251–264PubMedCrossRef
5.
go back to reference Bucher HC, Cook RJ, Guyatt GH, Lang JD, Cook DJ, Hatala R, Hunt DL (1996) Effects of dietary calcium supplementation on blood pressure. A meta-analysis of randomized controlled trials. JAMA 275:1016–1022PubMedCrossRef Bucher HC, Cook RJ, Guyatt GH, Lang JD, Cook DJ, Hatala R, Hunt DL (1996) Effects of dietary calcium supplementation on blood pressure. A meta-analysis of randomized controlled trials. JAMA 275:1016–1022PubMedCrossRef
6.
go back to reference McCarron DA, Pingree PA, Rubin RJ, Gaucher SM, Molitch M, Krutzik S (1980) Enhanced parathyroid function in essential hypertension: a homeostatic response to a urinary calcium leak. Hypertension 2:162–168PubMedCrossRef McCarron DA, Pingree PA, Rubin RJ, Gaucher SM, Molitch M, Krutzik S (1980) Enhanced parathyroid function in essential hypertension: a homeostatic response to a urinary calcium leak. Hypertension 2:162–168PubMedCrossRef
7.
go back to reference Cappuccio FP, Kalaitzidis R, Duneclift S, Eastwood JB (2000) Unravelling the links between calcium excretion, salt intake, hypertension, kidney stones and bone metabolism. J Nephrol 13:169–177PubMed Cappuccio FP, Kalaitzidis R, Duneclift S, Eastwood JB (2000) Unravelling the links between calcium excretion, salt intake, hypertension, kidney stones and bone metabolism. J Nephrol 13:169–177PubMed
8.
go back to reference Tsuda K, Nishio I, Masuyama Y (2001) Bone mineral density in women with essential hypertension. Am J Hypertens 14:704–707PubMedCrossRef Tsuda K, Nishio I, Masuyama Y (2001) Bone mineral density in women with essential hypertension. Am J Hypertens 14:704–707PubMedCrossRef
9.
go back to reference MacGregor GA, Cappuccio FP (1993) The kidney and essential hypertension: a link to osteoporosis? J Hypertens 11:781–785PubMedCrossRef MacGregor GA, Cappuccio FP (1993) The kidney and essential hypertension: a link to osteoporosis? J Hypertens 11:781–785PubMedCrossRef
10.
go back to reference Schoofs MW, van der Klift M, Hofman A, de Laet CE, Herings RM, Stijnen T, Pols HA, Stricker BH (2008) Thiazide diuretics and the risk for hip fracture. Ann Intern Med 139:476–482CrossRef Schoofs MW, van der Klift M, Hofman A, de Laet CE, Herings RM, Stijnen T, Pols HA, Stricker BH (2008) Thiazide diuretics and the risk for hip fracture. Ann Intern Med 139:476–482CrossRef
11.
go back to reference Schlienger RG, Kraenzlin ME, Jick SS, Meier CR (2004) Use of β-blockers and risk of fractures. JAMA 292:1326–1332PubMedCrossRef Schlienger RG, Kraenzlin ME, Jick SS, Meier CR (2004) Use of β-blockers and risk of fractures. JAMA 292:1326–1332PubMedCrossRef
12.
go back to reference von der Recke P, Hansen MA, Hassager C (1999) The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 106:273–278PubMedCrossRef von der Recke P, Hansen MA, Hassager C (1999) The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 106:273–278PubMedCrossRef
13.
go back to reference Taylor BC, Schreiner PJ, Zmuda JM, Li J, Moffett SP, Beck TJ, Cummings SR, Lee JM, Walker K, Ensrud KE, SOF Research Group (2006) Association of endothelial nitric oxide Synthase genotypes with bone mineral density, bone loss, hip fracture and risk of fracture in older women: The SOF study. Bone 39:174–180 Taylor BC, Schreiner PJ, Zmuda JM, Li J, Moffett SP, Beck TJ, Cummings SR, Lee JM, Walker K, Ensrud KE, SOF Research Group (2006) Association of endothelial nitric oxide Synthase genotypes with bone mineral density, bone loss, hip fracture and risk of fracture in older women: The SOF study. Bone 39:174–180
14.
go back to reference Cho K, Demissie S, Dupuis J, Cupples LA, Kathiresan S, Beck TJ, Karasik D, Kiel DP (2008) Polymorphisms in the endothelial nitric oxide synthase gene and bone density/ultrasound and geometry in humans. Bone 42:53–60PubMedCentralPubMedCrossRef Cho K, Demissie S, Dupuis J, Cupples LA, Kathiresan S, Beck TJ, Karasik D, Kiel DP (2008) Polymorphisms in the endothelial nitric oxide synthase gene and bone density/ultrasound and geometry in humans. Bone 42:53–60PubMedCentralPubMedCrossRef
15.
go back to reference Firat SC, Cetin Z, Samanci N, Aydin F, Balci N, Gungor F, Firat MZ, Luleci G, Karauzum SB (2009) Evaluation of eNOS gene polymorphisms in relation to BMD in postmenopausal women. Maturitas 63:352–356PubMedCrossRef Firat SC, Cetin Z, Samanci N, Aydin F, Balci N, Gungor F, Firat MZ, Luleci G, Karauzum SB (2009) Evaluation of eNOS gene polymorphisms in relation to BMD in postmenopausal women. Maturitas 63:352–356PubMedCrossRef
16.
go back to reference Liu SZ, Yan H, Hou WK, Xu P, Tian J, Tian LF, Zhu BF, Ma J, Lu SM (2009) Relationships between endothelial nitric oxide synthase gene polymorphisms and osteoporosis in postmenopausal women. J Zhejiang Uni Sci B 10:609–618CrossRef Liu SZ, Yan H, Hou WK, Xu P, Tian J, Tian LF, Zhu BF, Ma J, Lu SM (2009) Relationships between endothelial nitric oxide synthase gene polymorphisms and osteoporosis in postmenopausal women. J Zhejiang Uni Sci B 10:609–618CrossRef
17.
go back to reference Vallance P, Collier J, Moncada S (1989) Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2:997–1000PubMedCrossRef Vallance P, Collier J, Moncada S (1989) Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2:997–1000PubMedCrossRef
18.
go back to reference Hukkanen MV, Platts LA, Fernandez dMI, O’Shaughnessy M, MacIntyre I, Polak JM (1999) Developmental regulation of nitric oxide synthase expression in rat skeletal bone. J Bone Miner Res 14:868–877PubMedCrossRef Hukkanen MV, Platts LA, Fernandez dMI, O’Shaughnessy M, MacIntyre I, Polak JM (1999) Developmental regulation of nitric oxide synthase expression in rat skeletal bone. J Bone Miner Res 14:868–877PubMedCrossRef
19.
go back to reference World Health Organization (WHO) (1993) Consensus development conference, diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 94:646–650CrossRef World Health Organization (WHO) (1993) Consensus development conference, diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 94:646–650CrossRef
20.
go back to reference Srivastava K, Narang R, Sreenivas V, Das S, Das N (2008) Association of eNOS Glu298ASP gene polymorphism with essential hypertension in Asian Indians. Clin Chim Acta 387:80–83PubMedCrossRef Srivastava K, Narang R, Sreenivas V, Das S, Das N (2008) Association of eNOS Glu298ASP gene polymorphism with essential hypertension in Asian Indians. Clin Chim Acta 387:80–83PubMedCrossRef
21.
go back to reference Excoffier L, Laval G, Schneider S (2007) Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online 1:47–50PubMedCentralPubMed Excoffier L, Laval G, Schneider S (2007) Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online 1:47–50PubMedCentralPubMed
24.
go back to reference Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377:239–242PubMedCrossRef Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377:239–242PubMedCrossRef
25.
go back to reference Alam I, Sun Q, Liu L, Koller DL, Fishburn T, Carr LG, Econs MJ, Foroud T, Turner CH (2006) Identification of a quantitative trait locus on rat chromosome 4 that is strongly linked to femoral neck structure and strength. Bone 39:93–99PubMedCrossRef Alam I, Sun Q, Liu L, Koller DL, Fishburn T, Carr LG, Econs MJ, Foroud T, Turner CH (2006) Identification of a quantitative trait locus on rat chromosome 4 that is strongly linked to femoral neck structure and strength. Bone 39:93–99PubMedCrossRef
26.
go back to reference Li J, Cun Y, Tang WR, Wang Y, Li SN, Ouyang HR, Wu YR, Yu HJ, Xiao CJ (2011) Association of eNOS gene polymorphisms with essential hypertension in the Han population in southwestern China. Genet Mol Res 27:2202–2212CrossRef Li J, Cun Y, Tang WR, Wang Y, Li SN, Ouyang HR, Wu YR, Yu HJ, Xiao CJ (2011) Association of eNOS gene polymorphisms with essential hypertension in the Han population in southwestern China. Genet Mol Res 27:2202–2212CrossRef
27.
go back to reference Souza-Costa DC, Belo VA, Silva PS, Sertorio JT, Metzger IF, Lanna CM, Machado MA, Tanus-Santos JE (2011) eNOS haplotype associated with hypertension in obese children and adolescents. Int J Obes (Lond) 35:387–392CrossRef Souza-Costa DC, Belo VA, Silva PS, Sertorio JT, Metzger IF, Lanna CM, Machado MA, Tanus-Santos JE (2011) eNOS haplotype associated with hypertension in obese children and adolescents. Int J Obes (Lond) 35:387–392CrossRef
Metadata
Title
A susceptibility haplotype within the endothelial nitric oxide synthase gene influences bone mineral density in hypertensive women
Authors
Monica Singh
Puneetpal Singh
Surinder Singh
Pawan Kumar Juneja
Taranpal Kaur
Publication date
01-09-2014
Publisher
Springer Japan
Published in
Journal of Bone and Mineral Metabolism / Issue 5/2014
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-013-0533-y

Other articles of this Issue 5/2014

Journal of Bone and Mineral Metabolism 5/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.